GABRIELE ZAMPERLINI NETTO

Índice h a partir de 2011
1
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/36 - Laboratório de Pediatria Clínica, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

Tipo de acesso: restrictedAccess ×

Resultados de Busca

Agora exibindo 1 - 10 de 10
  • conferenceObject
    PRIMARY CARDIAC TUMORS IN CHILDREN: A SINGLE INSTITUTION CASE SERIES
    (2022) ZAMPERLINI-NETTO, Gabriele; CRISTOFANI, Lilian; VELLASCO, Andressa; GONCALVES, Fernanda; BUENO, Gabrielle; TEIXEIRA, Roberto; ODONE FILHO, Vicente
  • conferenceObject
    Biphenotypic Acute Leukemia: Results From a Group of Patients Treated at a Single Hospital
    (2020) KROHLING, D.; GUEDES, G.; CORREA, A.; SILVA, M.; GOMEZ, K.; NERO, L. Del; BREVIGLIERI, C.; ZAMPERLINI-NETTO, G.; ALMEIDA, M.; ODONE-FILHO, V.; CRISTOFANI, L.
  • conferenceObject
    RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME: SINGLE INSTITUTION RETROSPECTIVE STUDY
    (2022) MACHADO, Ana Rahal Guaragna; FLORES, Angelica Hidalgo; SILVA, Aline Rodrigues Da; ZAMPERLINI-NETTO, Gabriele; BECHARAMAFRA, Ana; BARBUTO, Tomas Marzagao; CRISTOFANI, Lilian; ODONE FILHO, Vicente; GARCIA, Julia Lopes; FERNANDES, Juliana Folloni
  • conferenceObject
    Relapsed Acute Lymphoblastic Leukemia and Blinatumomab: Results From a Single Institution in Brazil Universidade de Sao Paulo
    (2020) ZAMPERLINI-NETTO, G.; FONSECA, M.; ALMEIDA, M.; ODONE-FILHO, V.; TEIXEIRA, R.; FERNANDES, J.; AZAMBUJA, A.; DUTRA, A.; BREVIGLIERI, C.; CRISTOFANI, L.
  • conferenceObject
    LONG TERM COMPLICATIONS IN CHILDREN TREATED FOR ADVANCED NEUROBLASTOMA
    (2012) HALLEY, Nathalia; CRISTOFANI, Lilian Maria; ALMEIDA, Maria Teresa Assis; MALUF-JUNIOR, Paulo Taufi; CORNACCHIONI, Ana Lucia Beltrati; TEIXEIRA, Roberto Augusto Plaza; ZAMPERLINI-NETO, Gabriele; GOMES, Alessandra Araujo; ODONE-FILHO, Vicente
    Purpose: Advanced neuroblastoma (stage 3 and 4) requires aggressive treatment, including surgery, chemo and radiotherapy and autologous bone marrow transplantation. Although long term survival rates are disappointing, those children who survive are prone to develop long term complications. Our aim is to report the long term complications rate and quality in children treated for stage 3 and 4 neuroblastoma. Methods: The charts of stage 3 and 4 children with neuroblastoma treated from January/1983 through October/2003 were reviewed and those surviving and with no evidence of disease for more than 5 years were selected. Late effects were classified as second malignancies, endocrinological, neuromotor, hepatic, sensorial, benign tumors, infectious diseases and psychiatric disease and others. Associations with treatment modalities were disclosed. Results: Among 263 children with stage 3 and 4 neuroblastoma, 40 (15%) are long term survivors. 20/40 (50%) present one or more complications, being 2 (10%) second malignant neoplasia, 4 (20%) endocrinological disturbances, 4 (20%) neuromotor, 5 (25%) hepatic, 4 (20%) sensorial, 3 (1.1%) benign tumors, and infertility, psychiatric disease and hepatitis C infection in 1 (5%) episode each. 10/20 (50%) of the children were less than 18 months at diagnosis, and 12/20 (60%) were stage 3 and 8/20 (40%) were stage 4. All children were submitted to chemotherapy and 7/20 (35%) to autologous bone marrow transplantation. In 10/20 (50%) patients radiotherapy was also included, and 4/10 (40%) presented functional lesions in the irradiated field. All endocrinologic sequelae were detected in the ABMT group. Second malignant neoplasia were not related to RDT(1 ALL and 1 thyroid carcinoma). Conclusion: Children surviving aggressive therapy for neuroblastoma are at risk of late effects, particularly endocrinological and neurological complications, requiring close observation to prompt intervention when necessary, avoiding impairments in quality of life or even life threatening situations. Second malignant neoplasia require special concern.
  • conferenceObject
    Blinatumomab (BLINA) as Sole Therapy for Relapsed Acute Leukemia (ALL) after Allogenic Hematopoietic Stem Cell Transplantation (HSCT)
    (2020) PEREIRA, P.; VINCE, C.; BRUMATTI, M.; HALLEY, N.; AZAMBUJA, A.; FERNANDES, J.; HAMERSCHLAK, N.; ZAMPERLINI-NETTO, G.; PEREIRA, A.; KROHLING, D.; ODONE-FILHO, V.
  • conferenceObject
    OUTCOMES FOLLOWING RELAPSE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH ALL: A SINGLE-CENTER EXPERIENCE
    (2022) MACHADO, Ana Rahal Guaragna; SANTOS, Camila Noronha; SION, Julia Loureiro; MORIKAWA, Karina Morikawa; ZAMPERLINI-NETTO, Gabriele; CRISTOFANI, Lilian; ODONE FILHO, Vicente; GOMES, Alessandra Araujo; FERNANDES, Juliana Folloni; GARCIA, Julia Lopes
  • bookPart
    Linfo-histiocitose hemofagocítica e síndrome de ativação macrofágica
    (2023) ELIAS, Adriana Maluf; ZAMPERLINI NETTO, Gabriele; ZAMPERLINI, Marcela Preto
  • conferenceObject
    Hydroxyurea (HU) Therapy for Patients With Post-Transplant Lymphoproliferative Disease (PTLD): Treatment and Prevention of New Episodes
    (2020) PEREIRA, P.; VINCE, C.; AZAMBUJA, A.; BRUMATTI, M.; CRISTOFANI, L.; HALLEY, N.; PEREIRA, A.; ZAMPERLINI-NETTO, G.; GUEDES, G.; ODONE-FILHO, V.
  • article 1 Citação(ões) na Scopus
    Point-of-Care Ultrasound Findings Associated With Langerhans Cell Histiocytosis in the Pediatric Emergency Department
    (2016) PRETO-ZAMPERLINI, Marcela; WEERDENBURG, Kirstin; ZAMPERLINI-NETTO, Gabriele; FISCHER, Jason W.
    Langerhans cell histiocytosis is a rare disease characterized by clonal proliferation of Langerhans-type cells, causing local or systemic effects. One of the most affected sites in children is the skull. We describe 2 cases of children presenting to the pediatric emergency department with symptoms isolated to the scalp and the point-of-care focused skull ultrasound findings, which assisted in the diagnosis of Langerhans cell histiocytosis in both cases.